comparemela.com
Home
Live Updates
FASENRA approved for treatment of children aged 6 to 11 with
FASENRA approved for treatment of children aged 6 to 11 with
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Additional indication for pediatric patients with severe eosinophilic asthma
...
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Japan ,
Liz Bodin ,
Lynda Mitchell ,
Minerva Pediatr ,
Biowa Inc ,
Astrazeneca ,
Allergy Asthma Network ,
Drug Administration ,
World Health Organization ,
Kyowa Kirin Co Ltd ,
Asthma Network ,
Vice President ,
Asthma Symptoms ,
Prescribing Information ,
Patient Information ,
Rare Diseases ,
Pediatri Allergy Immunol ,
Allergy Clin ,
Zeneca Annual Report ,
Very Severe Chronic Obstructive Pulmonary Disease ,
Frequent Exacerbations ,
Safety Study ,
Patients With Hypereosinophilic Syndrome ,